Hillary Griffin
Physician Assistant · Howell, MINPI 1144521782
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,157 of the $12,608 with a category attached, or 72.6%. 41 manufacturers reported payments, led by Pfizer at 24.5% of the total. 2025 is the largest year on record at $5,569, 9.1 times the $610 reported in 2021. Among physician assistant clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 529 payments — averaging $23.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$3K
- Johnson & Johnson$1K
- AbbVie$1K
- Novartis$698
- UCB, Inc.$649
- E.r. Squibb & Sons, L.L.C.$618
- plus $5K from 35 others
What the payments were for
- Consulting fees$2,70021%
- Food & beverage$9,15773%
- Education$7516%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 23 | $3,091 |
| Johnson & Johnson(2 entities) | 67 | $1,473 |
| AbbVie | 76 | $1,293 |
| Novartis | 64 | $698 |
| UCB, Inc. | 24 | $649 |
| E.r. Squibb & Sons, L.L.C. | 28 | $618 |
| Galderma Laboratories, L.p. | 32 | $505 |
| Amgen | 25 | $457 |
| Lilly USA, LLC | 17 | $434 |
| Regeneron Healthcare Solutions, Inc. | 13 | $373 |
| Ironshore Pharmaceuticals Inc. | 23 | $371 |
| LEO Pharma Inc. | 22 | $276 |
| Sun Pharmaceutical Industries Inc. | 9 | $234 |
| Tris Pharma Inc | 15 | $224 |
| Sanofi | 9 | $219 |
| Incyte Corporation | 8 | $208 |
| Sanofi-aventis U.S. LLC | 2 | $185 |
| Boehringer Ingelheim | 8 | $172 |
| Dermavant Sciences, Inc. | 8 | $147 |
| Arcutis Biotherapeutics, Inc. | 7 | $124 |
| Adlon Therapeutics L.p. | 5 | $94 |
| Corium, LLC | 5 | $88 |
| Kaleo, Inc. | 4 | $74 |
| Merck | 4 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $62 |
| Neurelis, Inc. | 3 | $56 |
| Organon | 2 | $52 |
| Cranial Technologies, Inc | 3 | $49 |
| Teva Pharmaceuticals USA, Inc. | 3 | $43 |
| Fresenius Kabi USA, LLC | 2 | $42 |
| Sandoz | 2 | $38 |
| Aimmune Therapeutics, Inc. | 2 | $30 |
| Sanofi Pasteur Inc. | 2 | $26 |
| Verrica Pharmaceuticals Inc. | 1 | $20 |
| Botanix SB Inc | 1 | $19 |
| Almirall LLC | 1 | $19 |
| Organogenesis Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Seqirus USA Inc | 1 | $16 |
| AstraZeneca | 1 | $14 |
| LNHC, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,608 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 13 | $271,226 |
| CibinqoAbrocitinib | 12 | $107,382 |
| Cosentyx Sensoready (2 Pens)Secukinumab | 12 | $85,274 |
| Dupixent PenDupilumab | 19 | $75,916 |
| Betamethasone Dipropionate | 68 | $3,543 |
| Tacrolimus | 27 | $2,832 |
| Ketoconazole | 151 | $2,696 |
| Fluorouracil | 29 | $1,838 |
| Ammonium Lactate | 76 | $1,231 |
| Clobetasol Propionate | 30 | $968 |
| Clindamycin Phosphate | 36 | $681 |
| Triamcinolone Acetonide | 93 | $589 |
| Doxycycline Hyclate | 24 | $501 |
| Metronidazole | 12 | $497 |
| ValacyclovirValacyclovir Hcl | 17 | $356 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerCibinqo | $3,091 | $107,38212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in Howell
- Sarang PatelRoyal Oak$660K
- Beth SweneyAda$617K
- Zainab JishiCanton$596K
- Taylor HennrickAdrian$430K
- Erin van DykeGrand Rapids$346K
- Ashley AldridgeAnn Arbor$298K
- Derek SusallaRochester Hills$242K
- Gabrielle DamoreRoyal Oak$200K
- Melissa MickelsonKalamazoo$168K
- Patrick CooneyNew Baltimore$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.